Larry Shimp
Technik-/Wissenschafts-/F&E-Leiter bei Osteotech, Inc.
Profil
Larry Shimp is currently the Chief Technology Officer at Osteotech, Inc. He previously worked as a Scientist at FMC Corp.
Dr. Shimp holds a doctorate degree from the Massachusetts Institute of Technology and an undergraduate degree from Northwestern University.
Aktive Positionen von Larry Shimp
| Unternehmen | Position | Beginn |
|---|---|---|
Osteotech, Inc.
 Osteotech, Inc. Medical SpecialtiesHealth Technology Osteotech, Inc. develops biologic products for orthopedic, spinal, trauma, neurosurgical, and maxillofacial surgeons for use in surgical procedures. It operates in five segments: demineralized bone matrix, hybrid/synthetic, traditional tissue, spinal allograft, and client services. The company processes, markets, and distributes Xenograft bone tissue products, which are used as bone graft substitutes. The company was founded in 1986 and is headquartered in Eatontown, NJ. | Technik-/Wissenschafts-/F&E-Leiter | 01.05.1992 |
Ehemalige bekannte Positionen von Larry Shimp
| Unternehmen | Position | Ende |
|---|---|---|
| FMC CORPORATION | Corporate Officer/Principal | - |
Ausbildung von Larry Shimp
| Massachusetts Institute of Technology | Doctorate Degree |
| Northwestern University | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| FMC CORPORATION | Process Industries |
| Private Unternehmen | 1 |
|---|---|
Osteotech, Inc.
Osteotech, Inc. Medical SpecialtiesHealth Technology Osteotech, Inc. develops biologic products for orthopedic, spinal, trauma, neurosurgical, and maxillofacial surgeons for use in surgical procedures. It operates in five segments: demineralized bone matrix, hybrid/synthetic, traditional tissue, spinal allograft, and client services. The company processes, markets, and distributes Xenograft bone tissue products, which are used as bone graft substitutes. The company was founded in 1986 and is headquartered in Eatontown, NJ. | Health Technology |
